Author Topic: VAERS is a national vaccine safety surveillance program to report bad reactions  (Read 704 times)

0 Members and 1 Guest are viewing this topic.

Software Santa

  • Administrator
  • *****
  • Posts: 4281
  • OS:
  • Mac OS X 10.9 Mac OS X 10.9
  • Browser:
  • SeaMonkey 2.33.1 SeaMonkey 2.33.1
The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program that you can report adverse vaccine reactions to.

Nice to Know About!!! For more information about VAERS, call 1-800-822-7967

Quote
Have you or your child had a reaction following vaccination? Important note:
  • Contacte a su proveedor de salud
  • Visite el (si es necesario)



The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program co-sponsored by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS is a post-marketing safety surveillance program, collecting information about adverse events (possible side effects) that occur after the administration of vaccines licensed for use in the United States.

VAERS provides a nationwide mechanism by which adverse events following immunization may be reported, analyzed, and made available to the public. VAERS also provides a vehicle for disseminating vaccine safety-related information to parents and guardians, health care providers, vaccine manufacturers, state vaccine programs, and other constituencies.


The primary objectives of VAERS are to:
 
  • Detect new, unusual, or rare vaccine adverse events (VAEs);
  • Monitor increases in known adverse events;
  • Identify potential patient risk factors for particular types of adverse events;
  • Identify vaccine lots with increased numbers or types of reported adverse events; and
  • Assess the safety of newly licensed vaccines. 

The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program co-sponsored by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS is a post-marketing safety surveillance program that collects information about adverse events (possible side effects) that occur after the administration of vaccines licensed for use in the United States.

The National Childhood Vaccine Injury Act (NCVIA) of 1986 requires health professionals and vaccine manufacturers to report to the U.S. Department of Health and Human Services (HHS) specific adverse events that occur after the administration of routinely recommended vaccines. In response to NCVIA, CDC and FDA established VAERS in 1990 (Chen, Vaccine, 1994).

VAERS has demonstrated its public health importance by providing health scientists with signals about possible adverse events following immunization. In one instance, VAERS detected reports for intussusception over that what would be expected to occur by chance alone after the RotaShield rotavirus vaccine in 1999. Epidemiologic studies confirmed an increased risk, and these data contributed to the product's removal from the US market. In another example, VAERS determined that there may be a potential for a small increase in risk for  Guillain-Barre' syndrome (GBS) after the meningococcal conjugate vaccine, Menactra. As a result of this finding, a history of GBS became a contraindication to the vaccine and further controlled studies are currently underway to research this issue.

https://vaers.hhs.gov/index